Wanbury's full-year profit jumps 117% on better mix and procurement savings
Net profit surged to ₹66.1 crore for FY26, though a West Asia-related export disruption dented the final quarter.
What's new
- FY26 net profit jumped 117% to ₹66.1 crore on 8.5% higher revenue of ₹650.3 crore.
- Q4 revenue fell 4.3% to ₹164.6 crore due to API export disruptions from the West Asia crisis.
- Commercial launch of a new anaesthetic API from the Tanuku facility.
Why this matters
The annual profit surge confirms the payoff from Wanbury's product-mix and efficiency work. The Q4 revenue dip, however, is a direct hit from a geopolitical event, showing the export business remains exposed to logistics shocks outside management's control. The new API and a clean South Korean inspection are steps toward de-risking that exposure.
What we're watching
- Q1 FY27 export dispatch normalisation after the March disruption.
- Sales trajectory of the newly launched anaesthetic API.
- Whether the procurement and mix efficiencies hold as revenue scales.
The full read
Wanbury's full-year results show a stark contrast between profitability and top-line momentum. Net profit surged 117% to ₹66.1 crore as a better product mix and procurement efficiencies flowed straight to the bottom line. Revenue grew a more modest 8.5% to ₹650.3 crore. The disconnect sharpened in the final quarter: revenue slipped 4.3% to ₹164.6 crore after a March conflict in West Asia disrupted API export schedules. A ₹3.6 crore one-time charge couldn't stop quarterly profit from rising 7.2% to ₹21.7 crore. Beyond the financials, the company launched a new anaesthetic API from Tanuku and cleared a zero-observation inspection from South Korea's MFDS. The annual story is clear: margins improved. The quarterly story is a warning: the export channel is fragile.
Questions answered
- How did Wanbury drive a 117% profit increase on just 8.5% revenue growth?
- The company cited a better product mix, higher yields, and procurement efficiencies. These factors more than doubled EPS to ₹20.55, amplifying the profit impact of the moderate revenue gain.
- Why did the fourth quarter revenue decline?
- Q4 revenue fell 4.3% to ₹164.6 crore due to disruptions to API export dispatches caused by the West Asia crisis in March. The company characterized it as a timing issue.
- What was the one-time charge in Q4?
- Wanbury took a ₹3.6 crore one-time charge in the fourth quarter. Despite this hit, quarterly profit after tax still rose 7.2% to ₹21.7 crore.
- What are the key operational updates?
- Wanbury commercially launched a new anaesthetic API from its Tanuku facility and received a zero-observation inspection outcome from South Korea's MFDS, clearing a regulatory hurdle.